Neurological Complications at Stroke Patients With Diabetes Mellitus
SDM
2 other identifiers
observational
100
1 country
1
Brief Summary
It is to be investigated if a correlation exist between the development of the HbA1c value and the complication rate is following a stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2010
CompletedFirst Posted
Study publicly available on registry
July 30, 2010
CompletedStudy Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJune 23, 2011
June 1, 2011
7 months
July 28, 2010
June 21, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional outcome six months after the cerebral ischemia
Functional outcome for the National Institutes of Health Stroke scale, the Barthel Index and Modified Ranking Scala six months after the cerebral ischemia.
six months
Secondary Outcomes (2)
Additional cerebral ischemia
six months
Mortality
sixt months
Study Arms (2)
HbA1c ≤ 7
Stroke patients with mild diabetes mellitus HbA1c ≤ 7
HbA1c ≥ 7,5
Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
Eligibility Criteria
Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours
You may qualify if:
- Stroke patients on the Stroke Unit with hyperglycemia with cerebral ischemia within the last 24 hours
You may not qualify if:
- Patients with intracerebral hemorrhage
- Pregnant patients
- Patients with sensory aphasia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Evangelisches Krankenhaus
Bielefeld, 33167, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cristian Barzu, MD
Evangelisches Krankenhaus Bielefeld, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 28, 2010
First Posted
July 30, 2010
Study Start
August 1, 2010
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
June 23, 2011
Record last verified: 2011-06